Supplementary Table 1-8 from Spatially Resolved Tumor Ecosystems and Cell States in Gastric Adenocarcinoma Progression and Evolution

(1) Supplementary Table 1 shows GeoMx DSP ROI and scRNA-seq characteristics of samples profiled; (2) Supplementary Table 2 shows clinical characteristics of GeoMx DSP ROI and scRNA-seq samples profiled; (3) Supplementary Table 3A shows consistency between before and after batch effect removal on top enriched pathways in various ROI categories, 3B shows consistency between before and after batch effect removal on G1 and G2 labels on Tumor ROIs; (4) Supplementary Table 4 shows Silhouette scores of using different number of clusters in Tumor ROI hierarchical clustering; (5) Supplementary Table 5 shows detailed information of GeoMx ROIs in the TMA cohort; (6) Supplementary Table 6 shows top DEGs for endothelial cell subtypes (Endo1-Endo3); (7) Supplementary Table 7 shows top DEGs for macrophage cell subtypes (TAM1-TAM6); (8) Supplementary Table 8 shows top DEGs for fibroblast cell subtypes (Fib1-Fib4).